Innovations in Immunotherapy: Advancements in Cancer Vaccines and Immune Modulation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cancer Vaccines and Immunotherapy".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 39
Special Issue Editors
Interests: tumor immunology; pan-cancer; machine learning
Special Issues, Collections and Topics in MDPI journals
Interests: oncology; immunology; glioma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advancements in cancer vaccines aim to educate the immune system to recognize and destroy cancer cells, offering the potential for long-lasting protection against recurrence. Additionally, using model organisms has proven invaluable for discovering and validating immunotherapeutic strategies, enabling researchers to explore novel immune-modulating agents. Multi-omics approaches, integrating genomics, transcriptomics, proteomics, and metabolomics, have become essential in elucidating the complex interactions within tumors and their microenvironments. These comprehensive analyses are crucial for identifying new biomarkers and therapeutic targets, ultimately guiding the development of personalized immunotherapy regimens. Cancer vaccine technologies are still in development, and various formats have been explored in preclinical and clinical studies for off-the-shelf and personalized cancer vaccines. Cancer vaccines face a significant challenge. Shared antigen cancer vaccines can be mass-produced as ready-to-use, reducing production times and costs. In contrast, personalized neoantigen vaccines are treated as a stand-alone drug, demanding rapid drug production, scalability, and cost control needed to enable rapid clinical application. Adopting a synthetic vaccine technology that facilitates fast and cost-effective production is essential to address vaccine complexities. This Special Issue will focus on the advancement of cancer vaccines concentrated in several key areas including identifying immunogenic neoantigens, optimizing vectors and delivery platforms, and using multi-omics and precision medicine in cancer vaccine development.
Dr. Nan Zhang
Dr. Hao Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multi-omics
- cancer therapy
- precision medicine
- cancer vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
